Smith Sean Michael
- SEC CIK
- 0001914769
No open-market purchases or sales filed in the past year.
Current role at each company
- NGNE Neurogene Inc.Interim CFO, Prin Acct Offas of Aug 14, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Sean Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2023 (view filing) | Aug 11 | 3 days | Smith Sean MichaelInterim CFO, Prin Acct Off | SSale | −1.32K | $0.62 | −$820.26 | −5.8%21.6K after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Smith Sean MichaelPrincipal Accounting Officer | SSale | −3.32K | $0.60 | −$1.99K | −17.2%16.0K after | |
| Aug 12, 2022 (view filing) | Aug 10 | 2 days | Smith Sean MichaelPrincipal Accounting Officer | SSale | −1.66K | $0.99 | −$1.64K | −19.6%6.78K after |